MedPath

SALINOMYCIN (QILU) 12% Granules

Registration Number: MAL14030027HA

Approved
Approval ID

899aef231f0f81fc

Registration Number

MAL14030027HA

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types1 type
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (1)

25.00 kgAvailable
Package Size: 25.00 kg
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (1)

SALINOMYCIN SODIUMActive
Monograph: salinomycin sodium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SALINOMYCIN (QILU) 12% Granules - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform